4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol and Asthma

4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol has been researched along with Asthma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Bian, RL	1
Alves, AF; Bezerra Barros, GC; Ferreira, LAMP; Mozzini Monteiro, T; Paiva Ferreira, LKD; Pereira, RA; Piuvezam, MR	1

Other Studies

2 other study(ies) available for 4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol and Asthma

Article	Year
[Pharmacological studies on the antiasthmatic principle of essential oil of artemisia argyi--terpinenol-4 (author's transl)]. Zhonghua jie he he hu xi xi ji bing za zhi = Chinese journal of tuberculosis and respiratory diseases, 1981, Volume: 4, Issue:4 Topics: Animals; Asthma; Bacteria; Central Nervous System; Female; Guinea Pigs; Hypersensitivity; In Vitro Techniques; Male; Mice; Oils, Volatile; Rats; SRS-A; Terpenes; Trachea	1981
4-Carvomenthenol ameliorates the murine combined allergic rhinitis and asthma syndrome by inhibiting IL-13 and mucus production via p38MAPK/NF-κB signaling pathway axis. International immunopharmacology, 2020, Volume: 88 Topics: Allergens; Animals; Anti-Allergic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Female; Interleukin-13; Lung; Menthol; Mice, Inbred BALB C; Mucus; NF-kappa B; Ovalbumin; p38 Mitogen-Activated Protein Kinases; Rhinitis, Allergic; Signal Transduction; Syndrome	2020

Article

Year

[Pharmacological studies on the antiasthmatic principle of essential oil of artemisia argyi--terpinenol-4 (author's transl)].

Zhonghua jie he he hu xi xi ji bing za zhi = Chinese journal of tuberculosis and respiratory diseases, 1981, Volume: 4, Issue:4

Topics: Animals; Asthma; Bacteria; Central Nervous System; Female; Guinea Pigs; Hypersensitivity; In Vitro Techniques; Male; Mice; Oils, Volatile; Rats; SRS-A; Terpenes; Trachea

1981

4-Carvomenthenol ameliorates the murine combined allergic rhinitis and asthma syndrome by inhibiting IL-13 and mucus production via p38MAPK/NF-κB signaling pathway axis.

International immunopharmacology, 2020, Volume: 88

Topics: Allergens; Animals; Anti-Allergic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Female; Interleukin-13; Lung; Menthol; Mice, Inbred BALB C; Mucus; NF-kappa B; Ovalbumin; p38 Mitogen-Activated Protein Kinases; Rhinitis, Allergic; Signal Transduction; Syndrome

2020